DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 01 · Volume 36 · January 2003 DOI: 10.1055/s-002-2474

Original Paper

3
Grözinger, M.; Dragicevic, A.; Hiemke, C.; Shams, M.; Müller, M. J.; Härtter, S.: Melperone is an Inhibitor of the CYP2D6 Catalyzed O-demethylation of Venlafaxine
7
Isogawa, K.; Fujiki, M.; Akiyoshi, J.; Tsutsumi, T.; Horinouchi, Y.; Kodama, K.; Nagayama, H.: Anxiety Induced by Repetitive Transcranial Magnetic Stimulation is Suppressed by Chronic Treatment of Paroxetine in Rats
12
Frieboes, R.-M.; Sonntag, A.; Yassouridis, A.; Eap, C. B.; Baumann, P.; Steiger, A.: Clinical Outcome after Trimipramine in Patients with Delusional Depression - a Pilot Study
18
Hamann, J.; Leucht, S.; Kissling, W.: Are the Second-generation Antipsychotics Cost-effective? A Critical Review on the Background of Different Health Systems
27
Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: The High-affinity Non-peptide CRH1 Receptor Antagonist R121919 Attenuates Stress-induced Alterations in Plasma Oxytocin, Prolactin, and Testosterone Secretion in Rats

Letter

32
Zullino, D.; Borgeat, F.: Hypertension Induced by St. John’s Wort
33
Garroni, D.; Palloshi, A.; Fragasso, G.; Margonato, A.: Minimal Myocardial Damage after Tricyclic Neuroleptic Overdose
35
Eich-Höchli, D.; Oppliger, R.; Golay, K. Powell; Baumann, P.; Eap, C. B.: Methadone Maintenance Treatment and St. John’s Wort
37
Loeffler, S.; Fehsel, K.; Henning, U.; Fischer, J.; Agelink, M.; Kolb-Bachofen, V.; Klimke, A.: Increased Apoptosis of Neutrophils in a Case of Clozapine-induced Agranulocytosis
41
Chari, S.; Quraishi, S. H.; Jainer, A. K.: Fluoxetine-induced Exacerbation of Chorea in Huntington’s Disease?
43
Aleman, A.: Letter to the Editor

Letter to the Editor

44
Authors’ reply